Abstract
Benign prostatic hyperplasia (BPH) is a common disorder in men with an incidence that increases with age. BPH often requires therapy when patients begin to experience lower urinary tract symptoms that affect quality of life. Current management strategies involve lifestyle modifications, pharmacotherapy, phytotherapy, and surgical interventions as indicated. Pharmacists are in the unique position of being accessible sources of healthcare information for the BPH patient population. Understanding the symptoms of this disorder and therapy options will be beneficial for pharmacists who have increased chances to answer BPH-related questions from their patients.
| Original language | English (US) |
|---|---|
| Pages | 36-40 |
| Number of pages | 5 |
| Volume | 41 |
| No | 8 |
| Specialist publication | U.S. Pharmacist |
| State | Published - Aug 1 2016 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Pharmacy
- Pharmacology
- Pharmaceutical Science
Cite this
Guidelines for the treatment of benign prostatic hyperplasia. / Wu, Yunuo; Davidian, Michael H.; DeSimone, Edward M.
In: U.S. Pharmacist, Vol. 41, No. 8, 01.08.2016, p. 36-40.Research output: Contribution to specialist publication › Article
}
TY - GEN
T1 - Guidelines for the treatment of benign prostatic hyperplasia
AU - Wu, Yunuo
AU - Davidian, Michael H.
AU - DeSimone, Edward M.
PY - 2016/8/1
Y1 - 2016/8/1
N2 - Benign prostatic hyperplasia (BPH) is a common disorder in men with an incidence that increases with age. BPH often requires therapy when patients begin to experience lower urinary tract symptoms that affect quality of life. Current management strategies involve lifestyle modifications, pharmacotherapy, phytotherapy, and surgical interventions as indicated. Pharmacists are in the unique position of being accessible sources of healthcare information for the BPH patient population. Understanding the symptoms of this disorder and therapy options will be beneficial for pharmacists who have increased chances to answer BPH-related questions from their patients.
AB - Benign prostatic hyperplasia (BPH) is a common disorder in men with an incidence that increases with age. BPH often requires therapy when patients begin to experience lower urinary tract symptoms that affect quality of life. Current management strategies involve lifestyle modifications, pharmacotherapy, phytotherapy, and surgical interventions as indicated. Pharmacists are in the unique position of being accessible sources of healthcare information for the BPH patient population. Understanding the symptoms of this disorder and therapy options will be beneficial for pharmacists who have increased chances to answer BPH-related questions from their patients.
UR - http://www.scopus.com/inward/record.url?scp=84983085381&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84983085381&partnerID=8YFLogxK
M3 - Article
VL - 41
SP - 36
EP - 40
JO - U.S. Pharmacist
JF - U.S. Pharmacist
SN - 0148-4818
ER -